EVA Pharma’s roots stretch back over a hundred years.

thumbnail_Pharmacy.jpeg

Pharmacy.jpeg

Our History

Our experienced leadership team keeps us on track.

thumbnail_Find_Out_More_Leaders.png

Find_Out_More_Leaders.png

Meet our Leaders

EVA Pharma’s success is based on its dynamic team, Our people are our power.

thumbnail_1704997569480.jfif

1704997569480.jfif

Life at EVA Pharma

<h3>Active ingredients:</h3>
<p>28 mg Memantine extended release<br>10mg Donepzil</p>
<p>&nbsp;</p>
<h3>Drug usage indications:</h3>
<p>Treatment of moderate-to-severe dementia of the Alzheimer’s type</p>

imresizer-1720448784818.png

Nervous System

14mg Memantine extended release/10mg Donepzil 28mg Memantine extended release/10mg Donepzil

Donepezil

Houras Website EDA Approval QR.png

28mg Memantine extended release/10mg Donepzil-Treatment of moderate-to-severe dementia of the Alzheimer’s type

Treatment of moderate-to-severe dementia of the Alzheimer’s type

Are you a Healthcare professional?

HDF0133OA2446/082024

Donazepine

Treatment of moderate-to-severe dementia of the Alzheimer’s type

Active ingredients:

Drug usage indications:

Find out more about EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our experienced leadership team keeps us on track.

EVA Pharma’s success is based on its dynamic team, Our people are our power.